These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 23570327

  • 1. Efficacy and safety of linagliptin in type 2 diabetes subjects at high risk for renal and cardiovascular disease: a pooled analysis of six phase III clinical trials.
    von Eynatten M, Gong Y, Emser A, Woerle HJ.
    Cardiovasc Diabetol; 2013 Apr 09; 12():60. PubMed ID: 23570327
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor linagliptin in black/African American patients with type 2 diabetes: Pooled analysis from eight Phase III trials.
    Thrasher J, Kountz DS, Crowe S, Woerle HJ, von Eynatten M.
    Postgrad Med; 2015 Jun 09; 127(5):419-28. PubMed ID: 25840727
    [Abstract] [Full Text] [Related]

  • 3. Kidney Disease End Points in a Pooled Analysis of Individual Patient-Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes.
    Cooper ME, Perkovic V, McGill JB, Groop PH, Wanner C, Rosenstock J, Hehnke U, Woerle HJ, von Eynatten M.
    Am J Kidney Dis; 2015 Sep 09; 66(3):441-9. PubMed ID: 25960304
    [Abstract] [Full Text] [Related]

  • 4. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y, Neutel JM, Schumacher H.
    Clin Ther; 2005 Nov 09; 27(11):1795-805. PubMed ID: 16368450
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared With Placebo for Initial Treatment of Hypertension.
    Rodgers A, Salam A, Schutte AE, Cushman WC, de Silva HA, Di Tanna GL, Grobbee D, Narkiewicz K, Ojji DB, Poulter NR, Schlaich MP, Oparil S, Spiering W, Williams B, Wright JT, Gutierez A, Sanni A, Lakshman P, McMullen D, Ranasinghe G, Gianacas C, Shanthakumar M, Liu X, Wang N, Whelton P.
    J Am Coll Cardiol; 2024 Dec 10; 84(24):2393-2403. PubMed ID: 39217570
    [Abstract] [Full Text] [Related]

  • 6. Oral budesonide for induction of remission in ulcerative colitis.
    Sherlock ME, MacDonald JK, Griffiths AM, Steinhart AH, Seow CH.
    Cochrane Database Syst Rev; 2015 Oct 26; 2015(10):CD007698. PubMed ID: 26497719
    [Abstract] [Full Text] [Related]

  • 7. Safety and tolerability of linagliptin: a pooled analysis of data from randomized controlled trials in 3572 patients with type 2 diabetes mellitus.
    Schernthaner G, Barnett AH, Emser A, Patel S, Troost J, Woerle HJ, von Eynatten M.
    Diabetes Obes Metab; 2012 May 26; 14(5):470-8. PubMed ID: 22268497
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of linagliptin as monotherapy or add-on treatment in Asian patients with suboptimal glycemic control: a pooled analysis.
    Zeng Z, Choi DS, Mohan V, Emser A, Siddiqui K, Gong Y, Patel S, Woerle HJ.
    Curr Med Res Opin; 2015 Jan 26; 31(1):99-106. PubMed ID: 25215428
    [Abstract] [Full Text] [Related]

  • 9. Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trials.
    Chung S, Ben-Menachem E, Sperling MR, Rosenfeld W, Fountain NB, Benbadis S, Hebert D, Isojärvi J, Doty P.
    CNS Drugs; 2010 Dec 26; 24(12):1041-54. PubMed ID: 21090838
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial.
    Vermeire S, Schreiber S, Rubin DT, D'Haens G, Reinisch W, Watanabe M, Mehta R, Roblin X, Beales I, Gietka P, Hibi T, Hospodarskyy I, Ritter T, Genovese MC, Kwon P, Santermans E, Le Brun FO, Barron R, Masior T, Danese S.
    Lancet Gastroenterol Hepatol; 2024 Dec 02. PubMed ID: 39637881
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of lumacaftor/ivacaftor combination therapy in patients with cystic fibrosis homozygous for Phe508del CFTR by pulmonary function subgroup: a pooled analysis.
    Elborn JS, Ramsey BW, Boyle MP, Konstan MW, Huang X, Marigowda G, Waltz D, Wainwright CE, VX-809 TRAFFIC and TRANSPORT study groups.
    Lancet Respir Med; 2016 Aug 02; 4(8):617-626. PubMed ID: 27298017
    [Abstract] [Full Text] [Related]

  • 12. Etrolizumab for induction of remission in ulcerative colitis.
    Rosenfeld G, Parker CE, MacDonald JK, Bressler B.
    Cochrane Database Syst Rev; 2015 Dec 02; 2015(12):CD011661. PubMed ID: 26630451
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of nebivolol in stage I-II hypertension: a pooled analysis of data from three randomized, placebo-controlled monotherapy trials.
    Weiss RJ, Saunders E, Greathouse M.
    Clin Ther; 2011 Sep 02; 33(9):1150-61. PubMed ID: 21864908
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
    Wagg A, Wyndaele JJ, Sieber P.
    Am J Geriatr Pharmacother; 2006 Mar 02; 4(1):14-24. PubMed ID: 16730617
    [Abstract] [Full Text] [Related]

  • 15. Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia.
    Banach M, Duell PB, Gotto AM, Laufs U, Leiter LA, Mancini GBJ, Ray KK, Flaim J, Ye Z, Catapano AL.
    JAMA Cardiol; 2020 Oct 01; 5(10):1124-1135. PubMed ID: 32609313
    [Abstract] [Full Text] [Related]

  • 16. Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies.
    MacGregor EA, Pawsey SP, Campbell JC, Hu X.
    Gend Med; 2010 Apr 01; 7(2):88-108. PubMed ID: 20435272
    [Abstract] [Full Text] [Related]

  • 17. Methotrexate for maintenance of remission in Crohn's disease.
    Patel V, Wang Y, MacDonald JK, McDonald JW, Chande N.
    Cochrane Database Syst Rev; 2014 Aug 26; 2014(8):CD006884. PubMed ID: 25157445
    [Abstract] [Full Text] [Related]

  • 18. Diabetes-Related Composite Quality End Point Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical Trials.
    Bailey RA, Vijapurkar U, Meininger G, Rupnow MF, Blonde L.
    Clin Ther; 2015 May 01; 37(5):1045-54. PubMed ID: 25795432
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.
    Sasongko TH, Nagalla S.
    Cochrane Database Syst Rev; 2021 Dec 21; 12(12):CD009191. PubMed ID: 34932828
    [Abstract] [Full Text] [Related]

  • 20. Tramadol for neuropathic pain in adults.
    Duehmke RM, Derry S, Wiffen PJ, Bell RF, Aldington D, Moore RA.
    Cochrane Database Syst Rev; 2017 Jun 15; 6(6):CD003726. PubMed ID: 28616956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.